[1]
L. D. Popović Dragonjić et al., “Erythrocyte antioxidative enzymes activities in patients with chronic hepatitis C treated with pegylated interferon alpha-2a and ribavirin”, Vojnosanit Pregl, vol. 74, no. 9, pp. 840–848, Sept. 2017, doi: 10.2298/VSP150904277P.